Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)

Condition:   Diabetes Mellitus, Type 1 Interventions:   Drug: Plerixafor;   Drug: Alemtuzumab;   Drug: Anakinra;   Drug: Etanercept;   Drug: Liraglutide Sponsors:   University of Alberta;   Alberta Innovates Health Solutions Not yet recruiting - verified June 2017 (Source: ClinicalTrials.gov)

http://ift.tt/2s52qD2


http://ift.tt/2t2WbwZ

http://ift.tt/2r9XQ7h


http://ift.tt/2r3bCEW


http://ift.tt/2t2ZXpW


http://ift.tt/2smFlwv


http://ift.tt/2rekNRZ


from ! Medicine by Alexandros G. Sfakianakis via Αλέξανδρος Σφακιανάκης on Inoreader http://ift.tt/2resw2w
via IFTTT